Technology News and Research

RSS

AFFiRiS' AD02 Alzheimer's vaccine candidate in phase II clinical testing

AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.

24 Apr 2010

Health IT policy group calls for patient safety oversight program

Modern Healthcare: The federal Health Information Technology Policy Committee is calling for the development of a national program that would monitor patient safety problems in health care IT systems. "The first among the work group's recommendations was a proposal to create 'a national transparent oversight process and information system,' similar to a patient-safety organization, that could receive reports from various sources about patient-safety issues linked to the use of healthcare IT systems."

24 Apr 2010

Broadspire, Medcor partner to provide direct immediate post-injury treatment for employees

Broadspire, a Crawford Company and leading third party administrator of workers compensation claims, liability claims and medical management services, and Medcor, a leading injury triage provider, are partnering to implement services to more effectively direct immediate post-injury treatment for employees.

24 Apr 2010

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

"A year after the emergence of swine flu [H1N1], U.S. health authorities and laboratories say the pandemic illustrated the need for new vaccine production techniques that are faster and more reliable," Agence France-Presse writes in an article that examines the challenges associated with current vaccine development practices and plans for future development.

24 Apr 2010

NDSsi's ZeroWire Duo wireless Full HD video solution receives FDA clearance

NDS Surgical Imaging today announced it has received U.S. Food and Drug Administration 510(k) clearance for ZeroWire Duo, a Class II medical-grade wireless Full HD video solution for minimally-invasive surgery, GI and interventional suites.

24 Apr 2010

Misonix signs exclusive distribution agreement with Suministros Medicos Multimedicas

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year, exclusive distribution agreement with Suministros Medicos Multimedicas, based in Caracas, Venezuela, for the distribution of the SonaStar Ultrasonic Surgical Aspirator, the BoneScalpel Ultrasonic Bone Cutter, and the SonicOne Ultrasonic Wound Debrider.

24 Apr 2010

MedQuist completes purchase of domestic business of Spheris

MedQuist Inc., a leading provider of technology-enabled clinical documentation services, today announces that it has completed the purchase of the domestic business of Spheris Inc. Simultaneously, CBay Inc., MedQuist's majority owner, has acquired the stock of Spheris India Private Limited, a subsidiary of Spheris.

24 Apr 2010

JET Health Solutions introduces JET InsureFuse V3.0 for healthcare agents, underwriters and insurers

JET Health Solutions, the healthcare product and solutions division of AAJ Technologies, is premiering JET InsureFuse V3.0, an automated medical underwriting process system at LOMA's Health Underwriters Study Group Annual Meeting in San Antonio, Texas.

24 Apr 2010

ICTP to participate in QWeCl project to help fight malaria and other vector-borne illnesses

The Abdus Salam International Centre for Theoretical Physics is taking part in a newly-launched, major international, European Union-funded project to help fight malaria and other vector-borne illnesses by developing and deploying an early warning system for disease outbreaks in Africa.

24 Apr 2010

Johns Hopkins scientist receives AACR Award for Outstanding Achievement in Cancer Research

Joshua T. Mendell, M.D., Ph.D., an associate professor in the McKusick-Nathans Institute of Genetic Medicine at the Johns Hopkins University School of Medicine, and a Howard Hughes Medical Institute Early Career Scientist, is the recipient of the 30th annual American Association for Cancer Research Award for Outstanding Achievement in Cancer Research.

24 Apr 2010

Baptist Hospital East adopts CardiacAssist's TandemHeart System

CardiacAssist Inc. announced today that Baptist Hospital East has adopted the company's TandemHeart System.

23 Apr 2010

IDEXX Laboratories' first-quarter 2010 revenues increase 14% to $268.5M

IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.

23 Apr 2010

GIS scientists' zebrafish model may aid drug development for PD

Scientists at the Genome Institute of Singapore, a biomedical research institute of the Agency for Science, Technology and Research, have recently developed a zebrafish model for Parkinson's disease that can be used for understanding the mechanism underlying its development. The knowledge gained will be helpful for future screening of new drugs to treat Parkinson's disease.

23 Apr 2010

Crystal structures of key fluorescent proteins to "light up" molecules in cells

Scientists at Albert Einstein College of Medicine of Yeshiva University have determined the crystal structures of two key fluorescent proteins - one blue, one red - used to "light up" molecules in cells.

23 Apr 2010

Plant-based vaccine factory to produce vaccines and therapeutics within weeks of outbreaks

The Fraunhofer Center for Molecular Biotechnology in Newark, Delaware, the Fraunhofer Center for Manufacturing Innovation in Boston, Massachusetts, the Boston University College of Engineering, and the biopharmaceutical company iBio, Inc. in Newark, Delaware, announced today that they have developed a fully automated, scalable "factory" that uses natural (non-genetically-modified) green plants to efficiently produce large quantities of vaccines and therapeutics within weeks.

23 Apr 2010

GenVec's 2009 revenues down 8%: MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring GenVec Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

23 Apr 2010

EpiCept invites stockholders to attend Annual Meeting

With this notice, stockholders of EpiCept Corporation are invited to the Annual Meeting of Stockholders on June 3, 2010, at 10:00 a.m. Eastern time at the Dolce/IBM Palisades Executive Conference Center, 334 Route 9W, Palisades, New York 10964.

23 Apr 2010

European Patent Office intends to grant patent for Intezyne's IVECT Method

Intezyne today announced it has received notification the European Patent Office intends to grant a patent covering a key element of Intezyne's breakthrough drug delivery technology, the IVECT Method. At the core of this technology is the IVECT micelle, a proprietary, polymeric nanoparticle designed to encapsulate and deliver best-in-class therapeutics, while limiting exposure to healthy tissues.

23 Apr 2010

City of Manchester, Anthem Blue Cross and Blue Shield enhance Compass SmartShopper Program

Citing strong interest and engagement from city employees as well as requests from school district members, the city of Manchester and Anthem Blue Cross and Blue Shield in New Hampshire announced today enhancements to the innovative Compass SmartShopper Program as well as the addition of Manchester school district employees to the project.

23 Apr 2010

North Carolina GlaxoSmithKline Foundation awards $25,000 grants to 9 nonprofits

The North Carolina GlaxoSmithKline Foundation announced that it has awarded $25,000 grants to nine nonprofits this year, around the state to support activities that establish or expand programs that further science, education and health in local communities.

23 Apr 2010

Technology News and Research

AFFiRiS' AD02 Alzheimer's vaccine candidate in phase II clinical testing

Health IT policy group calls for patient safety oversight program

Broadspire, Medcor partner to provide direct immediate post-injury treatment for employees

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

NDSsi's ZeroWire Duo wireless Full HD video solution receives FDA clearance

Misonix signs exclusive distribution agreement with Suministros Medicos Multimedicas

MedQuist completes purchase of domestic business of Spheris

JET Health Solutions introduces JET InsureFuse V3.0 for healthcare agents, underwriters and insurers

ICTP to participate in QWeCl project to help fight malaria and other vector-borne illnesses

Johns Hopkins scientist receives AACR Award for Outstanding Achievement in Cancer Research

Baptist Hospital East adopts CardiacAssist's TandemHeart System

IDEXX Laboratories' first-quarter 2010 revenues increase 14% to $268.5M

GIS scientists' zebrafish model may aid drug development for PD

Crystal structures of key fluorescent proteins to "light up" molecules in cells

Plant-based vaccine factory to produce vaccines and therapeutics within weeks of outbreaks

GenVec's 2009 revenues down 8%: MicroStockProfit.com

EpiCept invites stockholders to attend Annual Meeting

European Patent Office intends to grant patent for Intezyne's IVECT Method

City of Manchester, Anthem Blue Cross and Blue Shield enhance Compass SmartShopper Program

North Carolina GlaxoSmithKline Foundation awards $25,000 grants to 9 nonprofits

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News